<DOC>
	<DOCNO>NCT00038025</DOCNO>
	<brief_summary>The purpose study determine side effect antitumor response patient lymphoid malignancy Deoxycoformycin ( DCF ) /Pentostatin .</brief_summary>
	<brief_title>A Study Of Deoxycoformycin ( DCF ) /Pentostatin In Lymphoid Malignancies</brief_title>
	<detailed_description>Deoxycoformycin ( DCF ) /Pentostatin T-cell cytotoxic drug previously report response lymphoid malignancy large study need .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Leukemia , Lymphocytic , Chronic , B-Cell</mesh_term>
	<mesh_term>Lymphoma , T-Cell</mesh_term>
	<mesh_term>Lymphoma , T-Cell , Peripheral</mesh_term>
	<mesh_term>Lymphoma , T-Cell , Cutaneous</mesh_term>
	<mesh_term>Pentostatin</mesh_term>
	<criteria>Histologic proof lymphoid malignancy expect complete response rate le 20 percent OR fail least one prior therapy . No chemotherapy within 3 week entry study must recover acute toxic effect prior therapy . Life expectancy least 12 week . Performance status equal less Zubrod 2 . Signed informed consent . Patients measurable disease . Age least 16 year . Adequate bone marrow function ( unless involvement bone marrow lymphoma ) define AGC great 1500 platelet count great 100,000 . Adequate hepatic function bilirubin less equal 1.5 mg % SGPT le equal 4 time upper limit normal . Adequate renal function define serum creatine less equal 1.5 mg % . No serious intercurrent illness . Adequate contraception ( applicable ) . NO patient significant cardiac disease , i.e . New York Heart Association ( NYHA ) class III IV . NO experimental clinical trial within 3 week study entry . NO patient active CNS disease . Full recovery prior surgical treatment . NO active active infection .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Mycosis Fungoides</keyword>
	<keyword>Lymphoma</keyword>
	<keyword>Chronic lymphocytic leukemia</keyword>
	<keyword>Deoxycoformycin</keyword>
	<keyword>Pentostatin</keyword>
	<keyword>All lymphoma</keyword>
	<keyword>Nucleoside analogue</keyword>
	<keyword>Adenosine deaminase inhibitor</keyword>
	<keyword>T-cells</keyword>
</DOC>